GlassScriptPhysician profile
Parkash Ashoke Bakhtiani
NPI 1821259649
$4,607.22
in general payments reported to CMS, 2019-2025
12 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,717 · 2020: $1,114 · 2021: $17.25 · 2022: $11.71 · 2023: $74.93 · 2024: $399 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708 · Education: $39.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.34 |
| Education | $39.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $3,800.00 | 2019-2020 | |
| Cequr Corporation | $312.41 | 2024-2025 | Cequr Simplicity |
| Medtronic, INC. | $165.31 | 2024 | Minimed 780g |
| Amgen INC. | $83.49 | 2025 | Evenity |
| Novo Nordisk INC | $56.82 | 2024-2025 | Sogroya, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $39.24 | 2023-2024 | |
| Mannkind Corporation | $35.00 | 2024 | |
| Abbott Laboratories | $34.63 | 2020-2023 | Jeti Peripheral Catheter |
| Dexcom, INC. | $34.61 | 2023 | Dexcom G6 Transmitter |
| Clarus Therapeutics INC. | $17.25 | 2021 | |
| Horizon Therapeutics Plc | $16.75 | 2019 | |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parkash Bakhtiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.